| 0 |
T-CELL LYMPHOMA UNCLASSIFIABLE |
1 |
0.5000 |
| 1 |
HEPATOSPLENIC T-CELL LYMPHOMA |
7 |
0.0189 |
| 2 |
POSTICTAL STATE |
12 |
0.0115 |
| 3 |
T-CELL LYMPHOMA |
12 |
0.0105 |
| 4 |
NECROTIC LYMPHADENOPATHY |
1 |
0.0083 |
| 5 |
SYMPTOM MASKED |
6 |
0.0082 |
| 6 |
PARANEOPLASTIC PEMPHIGUS |
1 |
0.0077 |
| 7 |
QUADRIPLEGIA |
14 |
0.0068 |
| 8 |
GLOMERULAR VASCULAR DISORDER |
1 |
0.0067 |
| 9 |
IMMUNOLOGY TEST ABNORMAL |
1 |
0.0064 |
| 10 |
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA |
2 |
0.0064 |
| 11 |
CELLULITE |
2 |
0.0061 |
| 12 |
EXTRADURAL HAEMATOMA |
8 |
0.0060 |
| 13 |
LOWER URINARY TRACT SYMPTOMS |
2 |
0.0055 |
| 14 |
LICE INFESTATION |
1 |
0.0048 |
| 15 |
DISSEMINATED CYTOMEGALOVIRAL INFECTION |
1 |
0.0046 |
| 16 |
MUCOSAL INFECTION |
1 |
0.0043 |
| 17 |
MYELOPATHY |
8 |
0.0042 |
| 18 |
VASOGENIC CEREBRAL OEDEMA |
3 |
0.0042 |
| 19 |
BIOPSY SKIN ABNORMAL |
1 |
0.0041 |
| 20 |
NASOPHARYNGEAL CANCER |
1 |
0.0038 |
| 21 |
ENTEROBACTER SEPSIS |
1 |
0.0027 |
| 22 |
TUMOUR ASSOCIATED FEVER |
1 |
0.0024 |
| 23 |
MYCOSIS FUNGOIDES |
2 |
0.0024 |
| 24 |
ALVEOLAR OSTEITIS |
1 |
0.0024 |
| 25 |
LYMPH GLAND INFECTION |
1 |
0.0022 |
| 26 |
WOLFF-PARKINSON-WHITE SYNDROME |
1 |
0.0021 |
| 27 |
VITREOUS DISORDER |
1 |
0.0021 |
| 28 |
NEUTROPENIC SEPSIS |
14 |
0.0020 |
| 29 |
SPINAL CORD COMPRESSION |
7 |
0.0018 |
| 30 |
INTRACRANIAL HAEMATOMA |
1 |
0.0018 |
| 31 |
ARTHRITIS REACTIVE |
1 |
0.0016 |
| 32 |
CUTANEOUS T-CELL LYMPHOMA |
2 |
0.0016 |
| 33 |
SEROMA |
2 |
0.0016 |
| 34 |
SMALL FIBRE NEUROPATHY |
1 |
0.0014 |
| 35 |
WOUND DRAINAGE |
1 |
0.0013 |
| 36 |
SINUSITIS FUNGAL |
1 |
0.0012 |
| 37 |
TONSIL CANCER |
1 |
0.0012 |
| 38 |
PANNICULITIS |
3 |
0.0012 |
| 39 |
BALANOPOSTHITIS |
1 |
0.0012 |
| 40 |
PERITONSILLAR ABSCESS |
1 |
0.0012 |
| 41 |
SERUM FERRITIN DECREASED |
2 |
0.0012 |
| 42 |
ENTEROCOLITIS INFECTIOUS |
1 |
0.0011 |
| 43 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 44 |
MUCOSAL DISORDER |
1 |
0.0010 |
| 45 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0010 |
| 46 |
STAPHYLOCOCCUS TEST POSITIVE |
2 |
0.0009 |
| 47 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
12 |
0.0009 |
| 48 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 49 |
PARALYSIS |
13 |
0.0009 |
| 50 |
METASTASES TO MENINGES |
2 |
0.0009 |
| 51 |
RECTAL ULCER |
1 |
0.0009 |
| 52 |
GENERALISED TONIC-CLONIC SEIZURE |
13 |
0.0008 |
| 53 |
DACRYOSTENOSIS ACQUIRED |
1 |
0.0008 |
| 54 |
MUCOSAL INFLAMMATION |
19 |
0.0007 |
| 55 |
VASCULAR PURPURA |
1 |
0.0007 |
| 56 |
H1N1 INFLUENZA |
1 |
0.0007 |
| 57 |
STRIDOR |
2 |
0.0007 |
| 58 |
IMPETIGO |
1 |
0.0007 |
| 59 |
COLON CANCER METASTATIC |
1 |
0.0006 |
| 60 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 61 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 62 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 63 |
HYPOGEUSIA |
1 |
0.0005 |
| 64 |
CYTOPENIA |
6 |
0.0005 |
| 65 |
LIPODYSTROPHY ACQUIRED |
1 |
0.0005 |
| 66 |
GASTROINTESTINAL ULCER |
1 |
0.0005 |
| 67 |
BACTERIAL TEST POSITIVE |
1 |
0.0004 |
| 68 |
LYMPHADENITIS |
1 |
0.0004 |
| 69 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 70 |
DYSLIPIDAEMIA |
2 |
0.0004 |
| 71 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 72 |
FAILURE TO THRIVE |
2 |
0.0004 |
| 73 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 74 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 75 |
SERUM SICKNESS |
1 |
0.0004 |
| 76 |
SINUS TACHYCARDIA |
5 |
0.0004 |
| 77 |
HYPERTRIGLYCERIDAEMIA |
2 |
0.0003 |
| 78 |
EMBOLISM VENOUS |
1 |
0.0003 |
| 79 |
LEUKAEMIA |
3 |
0.0003 |
| 80 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
3 |
0.0003 |
| 81 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 82 |
WOUND COMPLICATION |
1 |
0.0003 |
| 83 |
LYMPHOEDEMA |
2 |
0.0003 |
| 84 |
PETECHIAE |
3 |
0.0003 |
| 85 |
STOMATITIS |
17 |
0.0003 |
| 86 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 87 |
FEBRILE NEUTROPENIA |
18 |
0.0003 |
| 88 |
AMYLASE INCREASED |
1 |
0.0003 |
| 89 |
MALIGNANT NEOPLASM PROGRESSION |
27 |
0.0003 |
| 90 |
HYPOALBUMINAEMIA |
2 |
0.0003 |
| 91 |
THERAPY PARTIAL RESPONDER |
4 |
0.0003 |
| 92 |
HYPERPHAGIA |
1 |
0.0003 |
| 93 |
ORGAN FAILURE |
1 |
0.0002 |
| 94 |
DISEASE PROGRESSION |
29 |
0.0002 |
| 95 |
HYPERURICAEMIA |
1 |
0.0002 |
| 96 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
2 |
0.0002 |
| 97 |
EMBOLISM |
2 |
0.0002 |
| 98 |
IMMOBILE |
1 |
0.0002 |
| 99 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 100 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 101 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 102 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 103 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 104 |
ERYTHEMA MULTIFORME |
2 |
0.0002 |
| 105 |
SKIN ABRASION |
1 |
0.0002 |
| 106 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 107 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 108 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 109 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 110 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 111 |
NEUTROPHIL COUNT DECREASED |
8 |
0.0002 |
| 112 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 113 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 114 |
SKIN LESION |
5 |
0.0002 |
| 115 |
STEVENS-JOHNSON SYNDROME |
4 |
0.0002 |
| 116 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 117 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 118 |
THROMBOCYTOPENIA |
18 |
0.0002 |
| 119 |
SKIN MASS |
1 |
0.0001 |
| 120 |
NEUTROPENIA |
20 |
0.0001 |
| 121 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 122 |
HYPERGLYCAEMIA |
5 |
0.0001 |
| 123 |
ORAL DISORDER |
1 |
0.0001 |
| 124 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 125 |
DRUG INTOLERANCE |
13 |
0.0001 |
| 126 |
LUNG INFECTION |
2 |
0.0001 |
| 127 |
DECUBITUS ULCER |
1 |
0.0001 |
| 128 |
HICCUPS |
1 |
0.0001 |
| 129 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 130 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 131 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 132 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 133 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 134 |
AMENORRHOEA |
2 |
0.0001 |
| 135 |
DRUG ERUPTION |
2 |
0.0001 |
| 136 |
ANAEMIA |
21 |
0.0001 |
| 137 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 138 |
HYPOKALAEMIA |
5 |
0.0001 |
| 139 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 140 |
APPENDICITIS |
1 |
0.0001 |
| 141 |
HYPONATRAEMIA |
6 |
0.0001 |
| 142 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 143 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 144 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 145 |
ORAL HERPES |
2 |
0.0001 |
| 146 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 147 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 148 |
SKIN LACERATION |
1 |
0.0001 |
| 149 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 150 |
SEPSIS |
10 |
0.0001 |
| 151 |
ORAL PAIN |
2 |
0.0001 |
| 152 |
SKIN INFECTION |
1 |
0.0001 |
| 153 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 154 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 155 |
METASTASES TO LUNG |
1 |
0.0001 |
| 156 |
BACTERAEMIA |
1 |
0.0001 |
| 157 |
MYELOSUPPRESSION |
3 |
0.0001 |
| 158 |
NEURALGIA |
2 |
0.0001 |
| 159 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 160 |
PHARYNGITIS |
1 |
0.0001 |
| 161 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 162 |
HYPOPHAGIA |
2 |
0.0001 |
| 163 |
NODULE |
1 |
0.0001 |
| 164 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 165 |
TACHYPNOEA |
1 |
0.0001 |
| 166 |
PANCYTOPENIA |
4 |
0.0001 |
| 167 |
MASS |
1 |
0.0001 |
| 168 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 169 |
HERPES ZOSTER |
4 |
0.0001 |
| 170 |
PYREXIA |
23 |
0.0001 |
| 171 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 172 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 173 |
NEUROPATHY PERIPHERAL |
6 |
0.0001 |
| 174 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 175 |
CYSTITIS |
2 |
0.0001 |
| 176 |
ABSCESS |
1 |
0.0001 |
| 177 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 178 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 179 |
HAEMATURIA |
2 |
0.0001 |
| 180 |
HYPOXIA |
2 |
0.0001 |
| 181 |
PRODUCT USE IN UNAPPROVED INDICATION |
14 |
0.0001 |
| 182 |
PLATELET COUNT DECREASED |
6 |
0.0001 |
| 183 |
OEDEMA |
3 |
0.0001 |
| 184 |
PELVIC PAIN |
1 |
0.0001 |
| 185 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 186 |
PROTEINURIA |
1 |
0.0001 |
| 187 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 188 |
NASAL CONGESTION |
3 |
0.0001 |
| 189 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 190 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 191 |
PERITONITIS |
1 |
0.0000 |
| 192 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 193 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 194 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 195 |
SEPTIC SHOCK |
2 |
0.0000 |
| 196 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 197 |
DEHYDRATION |
6 |
0.0000 |
| 198 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 199 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 200 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 201 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 202 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 203 |
TOXICITY TO VARIOUS AGENTS |
7 |
0.0000 |
| 204 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 205 |
RESPIRATORY FAILURE |
3 |
0.0000 |
| 206 |
LIVER INJURY |
1 |
0.0000 |
| 207 |
ABASIA |
1 |
0.0000 |
| 208 |
EPISTAXIS |
3 |
0.0000 |
| 209 |
HAEMATEMESIS |
1 |
0.0000 |
| 210 |
DIABETES MELLITUS |
3 |
0.0000 |
| 211 |
DRUG RESISTANCE |
1 |
0.0000 |
| 212 |
DECREASED APPETITE |
9 |
0.0000 |
| 213 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 214 |
SKIN ULCER |
1 |
0.0000 |
| 215 |
DIPLOPIA |
1 |
0.0000 |
| 216 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 217 |
PAIN OF SKIN |
1 |
0.0000 |
| 218 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 219 |
PALLOR |
1 |
0.0000 |
| 220 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 221 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 222 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 223 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 224 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 225 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 226 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 227 |
HEAD INJURY |
1 |
0.0000 |
| 228 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 229 |
LIP SWELLING |
1 |
0.0000 |
| 230 |
URINARY RETENTION |
1 |
0.0000 |
| 231 |
DELIRIUM |
1 |
0.0000 |
| 232 |
HYPERKALAEMIA |
1 |
0.0000 |
| 233 |
INFECTION |
4 |
0.0000 |
| 234 |
BRONCHITIS |
2 |
0.0000 |
| 235 |
DRUG INEFFECTIVE |
35 |
0.0000 |
| 236 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 237 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 238 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 239 |
DRUG INTERACTION |
4 |
0.0000 |
| 240 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 241 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 242 |
PNEUMONIA |
8 |
0.0000 |
| 243 |
TREATMENT FAILURE |
2 |
0.0000 |
| 244 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 245 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 246 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 247 |
MENTAL DISORDER |
1 |
0.0000 |
| 248 |
LIVER DISORDER |
1 |
0.0000 |
| 249 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 250 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 251 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 252 |
ADVERSE EVENT |
2 |
0.0000 |
| 253 |
DIARRHOEA |
14 |
0.0000 |
| 254 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 255 |
WEIGHT DECREASED |
6 |
0.0000 |
| 256 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 257 |
CONTUSION |
2 |
0.0000 |
| 258 |
LEUKOPENIA |
1 |
0.0000 |
| 259 |
SYNCOPE |
2 |
0.0000 |
| 260 |
CELLULITIS |
1 |
0.0000 |
| 261 |
ERYTHEMA |
4 |
0.0000 |
| 262 |
INFLAMMATION |
1 |
0.0000 |
| 263 |
ECZEMA |
1 |
0.0000 |
| 264 |
ASTHENIA |
7 |
0.0000 |
| 265 |
OFF LABEL USE |
16 |
0.0000 |
| 266 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 267 |
COUGH |
5 |
0.0000 |
| 268 |
BLISTER |
1 |
0.0000 |
| 269 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 270 |
BONE PAIN |
1 |
0.0000 |
| 271 |
WHEEZING |
1 |
0.0000 |
| 272 |
FATIGUE |
13 |
0.0000 |
| 273 |
JOINT SWELLING |
2 |
0.0000 |
| 274 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 275 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 276 |
DYSPNOEA |
9 |
0.0000 |
| 277 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 278 |
NAUSEA |
12 |
0.0000 |
| 279 |
CONSTIPATION |
3 |
0.0000 |
| 280 |
MALAISE |
6 |
0.0000 |
| 281 |
DYSGEUSIA |
1 |
0.0000 |
| 282 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 283 |
VOMITING |
6 |
0.0000 |
| 284 |
THROMBOSIS |
1 |
0.0000 |
| 285 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 286 |
CARDIAC ARREST |
1 |
0.0000 |
| 287 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 288 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 289 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 290 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 291 |
TACHYCARDIA |
1 |
0.0000 |
| 292 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 293 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 294 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 295 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 296 |
HYPOTENSION |
2 |
0.0000 |
| 297 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 298 |
HYPERTENSION |
2 |
0.0000 |
| 299 |
SEIZURE |
1 |
0.0000 |
| 300 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 301 |
CHILLS |
1 |
0.0000 |
| 302 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 303 |
PAIN |
5 |
0.0000 |
| 304 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 305 |
DIZZINESS |
4 |
0.0000 |
| 306 |
ARTHRALGIA |
3 |
0.0000 |
| 307 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 308 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 309 |
COVID-19 |
1 |
0.0000 |
| 310 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 311 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 312 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 313 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 314 |
RASH |
2 |
0.0000 |
| 315 |
BACK PAIN |
1 |
0.0000 |
| 316 |
ANXIETY |
1 |
0.0000 |
| 317 |
DEATH |
3 |
0.0000 |
| 318 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 319 |
HEADACHE |
2 |
0.0000 |
| 320 |
FALL |
1 |
0.0000 |
| 321 |
PRURITUS |
1 |
0.0000 |